Antibody Engineering for Targeted Therapy of Cancer Recombinant Fv-Immunotoxins
Journal:
Current Pharmaceutical Biotechnology
Volume:
2
Page:
19-46
Author(s):
Revital Niv, Cyril J. Cohen, Galit Denkberg, Dina Segal and Yoram Reiter
Small Heat Shock Proteins (sHSPs) As Potential Drug Targets
Journal:
Current Pharmaceutical Biotechnology
Volume:
2
Page:
77-111
Author(s):
M. James C. Crabbe and Henry W. Hepburne-Scott
Preclinical Evaluation of New Anthracyclines
Journal:
Current Medicinal Chemistry
Volume:
8
Page:
9-13
Author(s):
G. Pratesi and S. V. Monestiroli
Cyclooxygenases in the Central Nervous System: Implications for Treatment of Neurological Disorders
Journal:
Current Pharmaceutical Design
Volume:
6
Page:
1755-1776
Author(s):
A. Yermakova and M. K. O'Banion
Protein Kinase C as a Drug Target Implications for Drug or Diet Prevention and Treatment of Cancer
Journal:
Current Drug Targets
Volume:
1
Page:
163-183
Author(s):
Charleata A. Carter
Antiangiogenic Gene Therapy in Cancer
Journal:
Current Genomics
Volume:
1
Page:
117-133
Author(s):
L. Zhang, Q. R. Chen and A. J. Mixson
Preface
Journal:
Current Pharmaceutical Design
Volume:
6
Page:
1123-1126
Author(s):
Kutlan Ozker
Toward The Rational Design of Cell Fate Modifiers Notch Signaling as a Target for Novel Biopharmaceuticals
Journal:
Current Pharmaceutical Biotechnology
Volume:
1
Page:
83-106
Author(s):
A. Zlobin, M. Jang and L. Miele
Inhibition of Cellular Proliferation by Drug Targeting of Cyclin-Dependent Kinases
Journal:
Current Pharmaceutical Biotechnology
Volume:
1
Page:
107-116
Author(s):
Ignacio Perez-Roger, Carmen Ivorra, Antonio Diez, Maria Jose Cortes, Enric Poch, Silvia M. Sanz-Gonzalez and Vicente Andres
Therapeutic Use of Chemokines
Journal:
Current Pharmaceutical Design
Volume:
6
Page:
651-663
Author(s):
Cory M. Hogaboam, Cynthia Bone-Larson, Akihiro Matsukawa, Matthew L. Steinhauser, Kate Blease, Nicholas W. Lukacs and Steven L. Kunkel